Folic acid
Synthetic oxidised form of folate. Metabolically less direct than natural folates or 5-MTHF. Critical for neural tube defect prevention in pregnancy. MTHFR variants may limit conversion.
How it works (mechanism of action)
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
MTHFR polymorphism: ~10% population homozygous for MTHFR C677T — reduced conversion to active 5-MTHF. Unmetabolised folic acid (UMFA) accumulation at high doses — unknown health significance. Mask B12 deficiency: high folic acid masks haematological signs of B12 deficiency while neurological damage continues. Drug interactions: methotrexate (antifolate drug — do not co-supplement without oncologist guidance), anticonvulsants (reduce folate levels).
